G Protein Coupled Receptors (GPCRs) are a class of proteins that are involved in a wide range of physiological processes, including cell signaling, metabolism, and homeostasis. They are the most abundant type of membrane receptor in the human body, and are involved in the regulation of many cellular processes. GPCRs are the target of many drugs, and are the focus of much research in the field of proteomics. Proteomics is the study of the structure and function of proteins, and GPCRs are a major focus of proteomics research. Proteomics research has enabled the development of new drugs and therapies that target GPCRs, and has also enabled the development of new diagnostic tools for diseases that involve GPCRs. Companies in the GPCR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
